Welcome to our dedicated page for Ainos SEC filings (Ticker: AIMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ainos, Inc. (NASDAQ: AIMD) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Texas corporation with shares listed on the Nasdaq Stock Market, Ainos submits periodic reports, proxy statements, and current reports that document its financial condition, governance decisions, and material agreements.
For investors tracking Ainos’ transition into an AI-powered digital olfaction and SmellTech company, Form 10-K annual reports and Form 10-Q quarterly reports are key sources for detailed discussions of the AI Nose platform, Smell Language Model (SLM), VELDONA oral interferon program, research and development spending, and risk factors. Form 8-K current reports capture material events such as financial result announcements, entry into or amendments of product development agreements, and other significant corporate actions.
Ainos’ DEF 14A proxy statements provide insight into board elections, auditor ratification, stock award proposals, and shareholder voting outcomes, reflecting how the company structures its governance and equity incentives. Filings also identify Ainos’ state of incorporation, trading symbols (AIMD for common stock and AIMDW for warrants), and other corporate details.
On Stock Titan, these filings are complemented by AI-powered summaries that highlight the most important points from lengthy documents, helping users quickly understand changes in capital structure, major contracts, or strategic direction without reading every page. Real-time updates from EDGAR ensure that new Ainos filings, including Forms 4 reporting insider transactions when available, appear promptly, while AI-generated overviews of 10-Ks and 10-Qs make complex disclosures more accessible to both experienced and newer investors.
Taiwan Carbon Nano Technology Corp, a 10% owner of Ainos, Inc., reported small open-market sales of Ainos common stock. On January 8, 2026, it sold 850 shares at $1.8048 per share, leaving 1,036,356 shares beneficially owned. On January 9, 2026, it sold an additional 431 shares at $1.86 per share, after which it held 1,035,925 shares directly.
According to the footnote, the reporting person sold these shares of common stock for general operating purposes.
Ainos, Inc. reported that on December 30, 2025 it entered into a distribution agreement with Trusval Technology Co. Ltd. covering its AINOS AI Nose and related products and services. The agreement runs for three years and provides Trusval with one-year exclusive distribution rights for Products sold to certain clients, after which exclusivity may change according to the contract terms. This arrangement is intended to govern how Ainos’ AI Nose offerings reach designated customers through Trusval as a distributor.
Ainos, Inc. (AIMD)November 25, 2025, the director received 50,000 shares of common stock as special stock awards at a price of $2.10 per share, increasing the director’s holdings to 91,280 shares held directly. The filing shows related derivative entries for 50,000 RSUs that were acquired and then converted into the same number of common shares on the same date.
The company’s stockholders had previously approved these special stock awards on November 7, 2025, indicating that this equity grant was part of an authorized compensation arrangement. This transaction aligns the director’s interests more closely with the performance of Ainos, Inc. through a larger direct ownership stake.
Ainos, Inc. (AIMD) reported an insider equity award for its CEO, President and Chairman, Chun-Hsien Tsai. On November 25, 2025, he acquired 80,000 shares of common stock at a reported price of $2.10 per share, classified as an acquisition of non-derivative securities. Following this transaction, he beneficially owned 410,372 shares of Ainos common stock directly.
The filing also shows related derivative activity, where 80,000 restricted stock units (RSUs) were converted into the same number of common shares and the RSU balance went to zero. The company notes these 80,000 shares were granted and vested as special stock awards on November 25, 2025, after having been approved by Ainos stockholders on November 7, 2025.
Ainos, Inc. (AIMD) director received a special stock award that resulted in the acquisition of 80,000 shares of common stock on November 25, 2025 at a price of $2.10 per share. These shares were granted and fully vested as special stock awards that had been approved by Ainos stockholders on November 7, 2025. Following this transaction, the reporting person now beneficially owns 365,707 shares of Ainos common stock directly.
Ainos, Inc. (AIMD) reported an insider equity award to one of its directors. On November 25, 2025, the reporting person received a grant of 50,000 shares of common stock as special stock awards, which were granted and vested on the same date at a reported price of $2.10 per share. These awards had been approved by Ainos stockholders on November 7, 2025.
Following this transaction, the director beneficially owns 101,546 shares of Ainos common stock in direct ownership. The filing also shows related movements in derivative securities (RSUs) that correspond to the 50,000 underlying common shares, with the RSU position moving to zero after conversion into common stock.
Ainos, Inc. (AIMD) reported an insider equity transaction by a director. On 11/25/2025, the reporting person received 50,000 shares of common stock as special stock awards at a reported price of $2.10 per share, increasing their directly held stake to 90,880 shares after the transaction. These 50,000 shares were granted and vested as part of special stock awards that had been approved by Ainos stockholders on 11/7/2025. The filing also shows related movements in restricted stock units and their conversion into common stock.
Ainos, Inc. (AIMD) reported that its Chief Financial Officer received a special stock award. On November 25, 2025, the CFO acquired 20,000 shares of common stock at a price of $2.10 per share, following the vesting of a restricted stock unit grant reported in the derivative table. After this transaction, the CFO beneficially owns 75,275 shares of Ainos common stock directly. The company’s stockholders had previously approved these special stock awards on November 7, 2025.
Ainos, Inc. (AIMD) reported an insider equity transaction by a director. On November 25, 2025, the director received 50,000 shares of common stock as special stock awards, which were granted and vested on that date. The awards were previously approved by Ainos stockholders on November 7, 2025.
The filing shows the 50,000 shares were acquired at a price of $2.10 per share, increasing the director’s directly held stake to 90,880 shares of Ainos common stock following the transaction. The Form 4 also reflects related movements in restricted stock units (RSUs) that converted into the same number of common shares.
Ainos, Inc. (AIMD)November 25, 2025, the reporting person, serving as a director, acquired 80,000 shares of common stock at $2.10 per share, following the vesting of 80,000 restricted stock units (RSUs) granted as special stock awards. After this transaction, the director beneficially owned 356,999 shares of Ainos common stock in direct ownership. The filing notes that these special stock awards were approved by Ainos stockholders on November 7, 2025.
FAQ
What is the current stock price of Ainos (AIMD)?
What is the market cap of Ainos (AIMD)?
